Acessibilidade / Reportar erro

A familial rearrangement(3;5;9) with paternal and maternal transmission leading to a duplication 3p/ deletion 5p infant

READERS OPINION

A familial rearrangement(3;5;9) with paternal and maternal transmission leading to a duplication 3p/ deletion 5p infant

Horacio RiveraI, II; María G. DomínguezI

IInstituto Mexicano del Seguro Social, División de Genética, CIBO, Guadalajara, México

IIUniversidad de Guadalajara, Genética Humana, CUCS, Guadalajara, México

We report a complex rea(3;5;9) observed in an unbalanced child who inherited this mutation from his mother and maternal grandfather.

The propositus, a male infant, was the only child of healthy non-consanguineous parents aged 28 (father) and 24 years. There was no history of miscarriages or malformations on either side of the family. The pregnancy and vaginal delivery were normal. The infant's birth weight and length were 2,450 g and 45 cm, respectively. Due to a complex heart defect (PDA, VSD, and ASD) and respiratory insufficiency, he was hospitalized for 30 days. Two months later, he underwent surgery to correct the cardiac defects. His psychomotor development was delayed. Clinical examination at 6 months of age revealed severe growth retardation (weight of 4.9 kg, length of 58 cm, OFC of 37 cm), hypotonia, diminished reflexes, brachycephaly, prominent forehead, bilateral ectropion and blepharophimosis, a small nose with anteverted nares, microstomia, micrognathia, a short neck, dysplastic and cupped ears, an osseous appendix in the sternum, and a single palmar crease in the left hand. The abdomen and external genitalia were normal. The patient had neither a cat-like cry nor telecanthus. One month later, the patient died of hypoventilation; no autopsy was performed.

The karyotypes of the patient and several relatives were determined using G-banding and Fluorescence in situ hybridization (FISH). The probes 3p (Vysis, Abbott Laboratories, Abbott Park, IL, USA)/5p (Cytocell, Cytocell Ltd., Cambridge, UK) subtel, ABL/BCR (Vysis, Abbott Laboratories, Abbott Park,IL,USA),andcriduchat/Sotos(Cytocell,CytocellLtd., Cambridge, UK) were used to test both the child and his mother; the mother was also tested with painting probes for chromosomes 3 and 9 (Cytocell, Cytocell Ltd., Cambridge, UK). This combined analysis led to the diagnosis of a familial 4-breakpoint rea(3;5;9) in both balanced and unbalanced forms (Figures 1 and 2). The patient had a duplication for 3p24.3—>pter concomitant with a deletion for 5p15.2—>pter due to a 46,XY,der(5)der(9)rea(3;5;9)(p24;p13.1p15.2;q22)mat.ish der(5) (5psubtel-,cri du chat-,ABL+)der(9)(3psubtel+,5psubtel-,ABL-) karyotype. In contrast, the mother's balanced complement was 46,XX,rea(3;5;9)(3qter—>3p24.3::5p15.2—>5pter;5qter—>5p13.1:: 9q22—.9qter;9pter—>9q22::5p13.1—.5p15.2::3p24.3—>3pter).ish der(3)(3psubtel-,5psubtel+,cri du chat+)der(5)(5psubtel-,cri du chat-,ABL+,wcp9+)der(9)(3psubtel+,cri du chat-,ABL-, wcp3+). The patient's maternal grandfather was also a balanced carrier, and the patient's father had a normal 46,XY karyotype.



The non-specific phenotype of the patient, including the lack of the cry and facies characteristic of the 5p deletion syndrome, can more parsimoniously be ascribed to his compound imbalance (1). The complex heart defect and death in infancy appear to be related to the 3p duplication(2).

Because the 5p segment can be regarded as ''inserted'' into the der(9), our observation may support the contention that complex chromosome rearrangements (CCR) with at least one insertional translocation can be transmitted either paternally or maternally and are refractory to recombination

Familial rearrangement(3;5;9) and duplication 3p/deletion 5p Rivera H and Dominguez MG CLINICS 2012;67(6):669-671 (3). The CCR of this patient — like other 3-chromosome rearrangements (4,5) — is expected to lead to imbalances predominantly via improper segregation.

Even if the unique nature of most CCRs requires the determination of the specific reproductive risks in each individual case (4,5), in general these risks appear to be greater than the corresponding empirical risks associated with reciprocal translocations, amounting to a ~50% risk of miscarriage and a ~20% risk of an unbalanced live infant (6). In addition to the gamete that led to the double imbalance in our patient, there are five other "adjacent-1" gametes that can be produced by carriers of the present CCR; notably, the counterpart der(3)/5/9 gamete would result in a viable del 3p/dup 5p unbalanced child. The theoretical "adjacent-2" (12 different gametes) and asymmetric 4:2, 5:1, or 6:0 segregations (44 gametes) are unlikely to be compatible with postnatal survival (except perhaps trisomy 9).

The involvement of chromosomes 3, 5, and 9 in the present CCR is consistent with the disproportionate participation of these chromosomes among the ~250 CCRs reported to date (5,7,8); the involvement of these chromosomes is even more disproportionate if all ~40 prenatally diagnosed instances are considered (9,10). Yet, this specific chromosomal combination has not apparently been described even though these three chromosomes were involved in a single more complex karyotype (11).

Finally, the fact that four de novo CCRs (12-15) and one de novo double balanced translocation (16) have been documented in fetuses (four female, one male) conceived after intracytoplasmic sperm injection should not be disregarded.

ACKNOWLEDGMENTS

We thank Dr. José E. García-Ortiz for his expert clinical assistance and the patient's parents for their valuable cooperation.

AUTHOR CONTRIBUTIONS

Rivera H designed the study and wrote the report. Domínguez MG performed the chromosomal analyses and critically reviewed the manuscript. Both authors approved the final version of the manuscript.

Email: hrivera@cencar.udg.mx

Tel.: 52 33 3618-9410

  • 1. Cerruti Mainardi P. Cri du chat syndrome. Orphanet J Rare Dis. 2006;1:33, http://dx.doi.org/10.1186/1750-1172-1-33
  • 2. Bittel DC, Kibiryeva N, Dasouki M, Knoll JH, Butler MG. A 9-year-old male with a duplication of chromosome 3p25.3p26.2: clinical report and gene expression analysis. Am J Med Genet. 2006;140A:573-9, http://dx.doi.org/10.1002/ajmg.a.31132
  • 3. Gruchy N, Barreau M, Kessler K, Gourdier D, Leporrier N. A paternally transmitted complex chromosomal rearrangement (CCR) involving chromosomes 2, 6, and 18 includes eight breakpoints and five insertional translocations (ITs) through three generations. Am J Med Genet. 2010;152A:185-90, http://dx.doi.org/10.1002/ajmg.a.33154
  • 4. Siffroi JP, Benzacken B, Straub B, Le Bourhis C, North MO, Curotti G, et al. Assisted reproductive technology and complex chromosomal rearrangements: the limits of ICSI. Mol Hum Reprod. 1997;3(10):847-51, http://dx.doi.org/10.1093/molehr/3.10.847
  • 5. Pellestor F, Anahory T, Lefort G, Puechberty J, Liehr T, Hédon B, et al. Complex chromosomal rearrangements: origin and meiotic behavior. Hum Reprod Update. 2011;17(4):476-94, http://dx.doi.org/10.1093/humupd/dmr010
  • 6. Madan K, Nieuwint AW, van Bever Y. Recombination in a balanced complex translocation of a mother leading to a balanced reciprocal translocation in the child. Review of 60 cases of balanced complex translocations. Hum Genet. 1997;99(6):806-15.
  • 7. Batanian JR, Eswara MS. De novo apparently balanced complex chromosome rearrangement (CCR) involving chromosomes 4, 18, and 21 in a girl with mental retardation: report and review. Am J Med Genet. 1998;78(1):44-51, http://dx.doi.org/10.1002/(SICI)1096-8628(19980616)78:1<44::AID-AJMG9>3.0.CO;2-L
  • 8. Lee NC, Chen M, Ma GC, Lee DJ, Wang TJ, Ke YY, et al. Complex rearrangements between chromosomes 6, 10, and 11 with multiple deletions at breakpoints. Am J Med Genet. 2010;152A:2327-34, http://dx.doi.org/10.1002/ajmg.a.33581
  • 9. Giardino D, Corti C, Ballarati L, Finelli P, Valtorta C, Botta G, et al. Prenatal diagnosis of a de novo complex chromosome rearrangement (CCR) mediated by six breakpoints, and a review of 20 prenatally ascertained CCRs. Prenat Diagn. 2006;26(6):565-70, http://dx.doi.org/10.1002/pd.1460
  • 10. Giardino D, Corti C, Ballarati L, Colombo D, Sala E, Villa N, et al. De novo balanced chromosome rearrangements in prenatal diagnosis. Prenat Diagn. 2009;29(3):257-65, http://dx.doi.org/10.1002/pd.2215
  • 11. Mechoso B, Vaglio A, Quadrelli A, Mark HF, Huang XL, Milunsky A, et al. A de novo complex chromosome rearrangement involving chromosomes 2, 3, 5, 9 and 11 detected prenatally and studied postnatally by conventional cytogenetics and molecular cytogenetic analyses. Fetal Diagn Ther. 2007;22(4):249-53, http://dx.doi.org/10.1159/000100784
  • 12. Houge G, Liehr T, Schoumans J, Ness GO, Solland K, Starke H, et al. Ten years follow up of a boy with a complex chromosomal rearrangement: going from a > 5 to 15-breakpoint CCR. Am J Med Genet. 2003;118A(3):235-40, http://dx.doi.org/10.1002/ajmg.a.10106
  • 13. Trimborn M, Liehr T, Belitz B, Pfeiffer L, Varon R, Neitzel H, et al. Prenatal diagnosis and molecular cytogenetic characterization of an unusual complex structural rearrangement in a pregnancy following intracytoplasmic sperm injection (ICSI). J Histochem Cytochem. 2005;53(3):351-4, http://dx.doi.org/10.1369/jhc.4B6412.2005
  • 14. Seller MJ, Bint S, Kavalier F, Brown RN, Ogilvie CM. Multicolor banding detects a complex three chromosome, seven breakpoint unbalanced rearrangement in an ICSI-derived fetus with multiple abnormalities. Am J Med Genet. 2006;140A(10):1102-7, http://dx.doi.org/10.1002/ajmg.a.31214
  • 15. Kasakyan S, Lohmann L, Aboura A, Quimsiyeh M, Menezo Y, Tachdjian G, et al. De novo complex intra chromosomal rearrangement after ICSI: characterisation by BACs micro array-CGH. Mol Cytogenet. 2008;1:27, http://dx.doi.org/10.1186/1755-8166-1-27
  • 16. Lev D, Malinger G, Chaki R, Reichler A, Glazerman M. Two de-novo balanced autosomal translocations after intracytoplasmic sperm injection. Lancet. 1999;353(9147):119, http://dx.doi.org/10.1016/S0140-6736(05)76155-9

Publication Dates

  • Publication in this collection
    29 June 2012
  • Date of issue
    2012
Faculdade de Medicina / USP Rua Dr Ovídio Pires de Campos, 225 - 6 and., 05403-010 São Paulo SP - Brazil, Tel.: (55 11) 2661-6235 - São Paulo - SP - Brazil
E-mail: clinics@hc.fm.usp.br